NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pneuma Respiratory

Pneuma Respiratory

Private
Boone, North CarolinaHealthcare & Life Scienceshttps://pneumarespiratory.com/

Last Round

Seed Round

Jul 1, 2026

Total Funding Raised

$18.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pneuma Respiratory is a therapeutic devices company that has developed a digital breath-activated inhaler and a therapeutic aerosol platform for pulmonary drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, D2C Brands, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

digital inhalersoft mist inhalersmart inhalerdrug delivery platformMedTechbreath-activated inhalersmoking cessationbiologics deliveryBDInicotine deliveryCOPD treatmentadherence monitoringaerosol deliveryHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pneuma Respiratory Comparables

Compare Pneuma Respiratory with similar companies based on industry and business-model similarity.

Pneuma Respiratory comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gilbert
79%
Merxin Ltd
78%
Teva Pharmaceuticals
71%

Pneuma Respiratory Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 1, 2026
DebtFeb 10, 2025
VC RoundJun 20, 2023
Corporate FundingAug 13, 2018
Series AJul 18, 2018

Pneuma Respiratory Investors

Notable investors and investment history

Pneuma Respiratory investors
InvestorRounds
High Country Impact FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Raised $4M in seed funding.

  • Jan 21, 2026

    Monthly visitors increased 1604% MoM, from 54 to 920.

Pneuma Respiratory Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pneuma Respiratory Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pneuma Respiratory's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoone, North Carolina
Employee Range11
Year Founded2015
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.